Good evening and welcome to today’s top U.S. breaking news.
A Medicare prescription-drug subsidy program that helped stabilize Part D premiums is set to end after 2026.
The Trump administration announced that the temporary premium-stabilization program will not continue into 2027.
The program was designed to help keep premiums from rising sharply for people enrolled in standalone Medicare Part D plans.
Around 25 million people are enrolled in standalone Part D coverage, according to recent reporting.
Officials say the subsidy was unnecessary and could encourage insurers to increase premiums because the government was absorbing part of the cost.
Critics warn that ending the program could mean higher monthly premiums for millions of seniors.
Some beneficiaries could see relatively small increases, while others may face substantially higher costs depending on their individual plans.
The change does not mean Medicare Part D itself is ending.
Instead, the temporary federal subsidy supporting premium stability is scheduled to expire after 2026.
Final 2027 premiums are expected to become clearer later this year as insurers finalize their plans.
Seniors should compare their available Part D plans during Medicare Open Enrollment before choosing coverage for 2027.
The development could become a major political issue as lawmakers debate prescription-drug affordability and healthcare costs.
For millions of Americans, the biggest question now is simple: How much more will their prescription coverage cost next year?
Stay with us for the latest U.S. breaking news, Medicare updates, healthcare developments, and Washington headlines.
